-
Millions of J&J Covid-19 vaccine doses scrapped after US ingredient mix-up
pharmaceutical-technology
April 02, 2021
Up to 15 million doses of Johnson & Johnson’s (J&J) Covid-19 vaccine have been ruined due to a mix-up with ingredients at a US production plant.
-
Colombia approves J&J Covid-19 vaccine for emergency use
pharmaceutical-technology
March 26, 2021
The Colombian National Food and Drug Surveillance Institute (INVIMA) has approved Johnson & Johnson’s (J&J) single-shot Covid-19 vaccine for emergency use in the country.
-
J&J developing many next-gen vaccines against COVID-19: CEO
expresspharma
March 19, 2021
Johnson & Johnson is developing several next-generation COVID-19 vaccines against the emerging variants of the coronavirus, said Alex Gorsky, CEO of the company.
-
Catalent Expands Partnership with J&J
contractpharma
March 18, 2021
Catalent Pharma Solutions has expanded its partnership with Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson.
-
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
contractpharma
March 16, 2021
Takeda Pharmaceutical has entered a mutual agreement with IDT Biologika GmbH, a contract development and manufacturing organization (CDMO), to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture ...
-
EMA approves fourth Covid-19 vaccine, J&J’s single-shot candidate
pharmaceutical-technology
March 12, 2021
The European Medicines Agency (EMA) has recommended conditional marketing authorisation for Johnson & Johnson (J&J) subsidiary Janssen’s Covid-19 vaccine.
-
J&J gets positive CHMP opinion for single-shot COVID-19 vaccine candidate
expresspharma
March 12, 2021
If granted conditional marketing authorisation by the EC, the J&J single-shot COVID-19 vaccine will be available in the EU.
-
Health Canada authorises J&J’s Covid-19 vaccine for emergency use
pharmaceutical-technology
March 09, 2021
Health Canada has authorised an Interim Order (IO) to the Janssen Pharmaceutical (JPI) Companies of Johnson & Johnson’s (J&J) single-shot vaccine preventing Covid-19 for people aged 18 above.
-
Reshaping the Pharmaceutical Supply Chain
contractpharma
March 02, 2021
The pandemic and COVID-19 vaccines bring navigating the cold-chain and preserving precious biologics to the forefront.
-
J&J’s COVID-19 shot gets CDC panel backing; vaccine near shipping
expresspharma
March 02, 2021
A US Centers for Disease Control and Prevention advisory panel voted unanimously on Sunday to recommend Johnson & Johnson’s COVID-19 shot for widespread use, and US officials said initial shipments would start on Sunday.